{{Rsnum
|rsid=2900174
|Gene=PRB2
|Chromosome=12
|position=11394598
|Orientation=plus
|GMAF=0.1166
|Gene_s=PRB2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 4.4 | 95.6
| HCB | 2.2 | 16.1 | 81.8
| JPT | 0.9 | 15.0 | 84.1
| YRI | 16.3 | 44.2 | 39.5
| ASW | 7.0 | 33.3 | 59.6
| CHB | 2.2 | 16.1 | 81.8
| CHD | 0.9 | 17.4 | 81.7
| GIH | 3.0 | 28.7 | 68.3
| LWK | 5.5 | 41.3 | 53.2
| MEX | 1.7 | 22.4 | 75.9
| MKK | 4.5 | 26.9 | 68.6
| TSI | 0.0 | 4.9 | 95.1
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22142827
|Trait=None
|Title=A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303.
|RiskAllele=G
|Pval=0.000001
|OR=3.3000
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}